BBH241220P145000
- 0.00
- 0.000.00%
VanEck Biotech ETF Newsroom
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Novo Nordisk, Super Micro Computer And Arm Are Among Top Large Cap Losers Last Week (December 16-20): Are The Others In Your Portfolio?
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Trending Stocks in Bearish Pre-holiday Week for U.S. Stock Market
Press Release: VanEck Announces Year-End Distributions for VanEck Equity ETFs
VanEck Biotech ETF To Go Ex-Dividend On December 23rd, 2024 With 1.2517 USD Dividend Per Share
Traders Fight The Grinch To Save The Santa Rally: 10 S&P 500 Stocks Poised For A Year-End Surge
Vertex Announces U.S. FDA Approval For TRIKAFTA To Include Additional Non-F508del TRIKAFTA-Responsive Variants
Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings
What's Going On With Amgen Stock On Friday?
IQVIA Hldgs Analyst Ratings
J.P. Morgan's Top Healthcare Stocks for 2025
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Why Is Novo Nordisk Crashing After Data for Next-gen Weight Loss Drug?
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Amgen Shares Are Trading Higher. Weight-loss Related Stocks Are up on Friday Following Weaker-than-expected Data From Competitor Lilly.
Needham Reiterates Hold on Vertex Pharmaceuticalsto Hold
BMO Capital Downgrades Biogen to Market Perform, Lowers Price Target to $164
Biogen Analyst Ratings